The Great Baby Food Shortage of 2022
- Thread starter nsacpi
- Start date
goldfly
<B>if my thought dreams could be seen</B>
First
Why do babies have a foot shortage?
First formula and food and now feet too?
****ing joe biden!!!
Second, no one is dismissing anything lol
For the love of god man, stop trying so hard
goldfly
<B>if my thought dreams could be seen</B>
Man, you’re one insufferable bastard lol
That’s obviously just making a joke about it
But whatever
I certainly don’t get a high from this place. Something to fill sometime here and there. It’s less fun since you went insane when thethe did his disappearance act after trump lost. But nice to know you do get a high from I guess. I mean, ya admitted that in the other thread
Sad but I guess everyone needs something
acesfull86
Well-known member
https://www.cato.org/blog/rock-bye-trade-restrictions-baby-formula
Over the last few months, a U.S. baby formula producer issued recalls both voluntarily and required by the Food and Drug Administration (FDA). These recalls are rocking the U.S. baby formula market leaving parents facing higher prices and bare shelves. Stores like Walgreens, CVS Health, and Target are limiting the number of formula products per purchase because of low inventory—just last month, national out‐of‐stock levels reached 40 percent!
One reason retailers are struggling to recover stock levels is the multifarious trade restrictions that limit infant formula imports. The United States subjects infant formula to tariffs up to 17.5 percent and tariff‐rate quotas (TRQs); for TRQs some level imported are subject to a tariff with the excess subject to a tariff and additional duties. A few trading partners receive “special” duty rates where some infant formula imports are duty‐free or receive lower tariffs and TRQs. Mexico is one of the few U.S. trading partners that has some duty‐free access for infant formula, and uncoincidentally, is the top trading partner for U.S. formula imports. Though, in comparison to total imports from Mexico (worth almost $400 billion), formula imports are extremely low.
Figure 1 illustrates how little baby formula the United States imports compared to its estimated domestic consumption. While it may not seem bad (and is even encouraged by many nowadays) that the U.S. does not import much baby formula, it is important to understand why the United States is not importing baby formula—amidst the current scarcity, the inability to import is detrimental as parents are left with few to no options.
Absurdly, provisions were added to the United States‐Mexico‐Canada Agreement (USMCA) to restrict imports of formula from Canada, supposedly because China was investing in a baby food plant in Ontario, and this new production might eventually enter the U.S. market (heaven forbid!). Thus, the provisions in the USMCA’s agriculture annex establish confusing and costly TRQs on Canadian exports of infant formula, and the United States imported no baby formula from Canada in 2021.
Making matters even worse, infant formula is subject to onerous U.S. regulatory (“non‐tariff”) barriers. For example, the FDA requires specific ingredients, labeling requirements, and mandates retailers wait at least 90 days before marketing a new infant formula. Therefore, if U.S. retailers wanted to source more formula from established trading partners like Mexico or Canada, the needs of parents cannot be quickly met because of these wait times. Businesses also have little incentive to go through the onerous regulatory process to sell to American retailers, given the aforementioned tariffs and the relatively short duration of the current crisis.
Over the last few months, a U.S. baby formula producer issued recalls both voluntarily and required by the Food and Drug Administration (FDA). These recalls are rocking the U.S. baby formula market leaving parents facing higher prices and bare shelves. Stores like Walgreens, CVS Health, and Target are limiting the number of formula products per purchase because of low inventory—just last month, national out‐of‐stock levels reached 40 percent!
One reason retailers are struggling to recover stock levels is the multifarious trade restrictions that limit infant formula imports. The United States subjects infant formula to tariffs up to 17.5 percent and tariff‐rate quotas (TRQs); for TRQs some level imported are subject to a tariff with the excess subject to a tariff and additional duties. A few trading partners receive “special” duty rates where some infant formula imports are duty‐free or receive lower tariffs and TRQs. Mexico is one of the few U.S. trading partners that has some duty‐free access for infant formula, and uncoincidentally, is the top trading partner for U.S. formula imports. Though, in comparison to total imports from Mexico (worth almost $400 billion), formula imports are extremely low.
Figure 1 illustrates how little baby formula the United States imports compared to its estimated domestic consumption. While it may not seem bad (and is even encouraged by many nowadays) that the U.S. does not import much baby formula, it is important to understand why the United States is not importing baby formula—amidst the current scarcity, the inability to import is detrimental as parents are left with few to no options.
Absurdly, provisions were added to the United States‐Mexico‐Canada Agreement (USMCA) to restrict imports of formula from Canada, supposedly because China was investing in a baby food plant in Ontario, and this new production might eventually enter the U.S. market (heaven forbid!). Thus, the provisions in the USMCA’s agriculture annex establish confusing and costly TRQs on Canadian exports of infant formula, and the United States imported no baby formula from Canada in 2021.
Making matters even worse, infant formula is subject to onerous U.S. regulatory (“non‐tariff”) barriers. For example, the FDA requires specific ingredients, labeling requirements, and mandates retailers wait at least 90 days before marketing a new infant formula. Therefore, if U.S. retailers wanted to source more formula from established trading partners like Mexico or Canada, the needs of parents cannot be quickly met because of these wait times. Businesses also have little incentive to go through the onerous regulatory process to sell to American retailers, given the aforementioned tariffs and the relatively short duration of the current crisis.
nsacpi
Expects Yuge Games
I just want to make sure that American children are safe from Nancy and the "usual pedo grifters" who surround her.
Btw my interest in the well-being of young Americans, especially those who find themselves born in impoverished circumstances, leads me to enthusiastically support enhanced refundable child tax credits. I'm even in favor of higher taxes on the rich to pay for that.
Last edited:
acesfull86
Well-known member
https://www.nationalreview.com/corner/house-republicans-were-right-to-vote-against-more-fda-funding/
The House of Representatives passed a bill yesterday that purports to address the baby-formula shortage. Introduced by House Democrats, the “Infant Formula Supplemental Appropriations Act” simply gives the Food and Drug Administration $28 million and doesn’t address any actual problems with the baby-formula market or the current shortage.
The bill passed 231 to 192, and all 192 votes against it came from Republicans. In response to criticism for voting against the bill, Representative Peter Meijer (R., Mich.) tweeted, “This one-page bill is just a $28M increase for FDA salaries. That’s it. If baby formula shortage was caused by an underfunded FDA, this would help. But it wasn’t.”
The FDA doesn’t need more money. As Meijer went on to say, the bill rewards “an agency that is performing its mission poorly with more money without connecting the funds requested to better achieving the mission. The moral hazard is self-evident.”
The FDA’s overly stringent regulation of baby formula — which mirrors its overly cautious approach to everything it regulates and costs American lives by denying safe treatments to patients who need them — is part of the reason the baby-formula market is so brittle in the first place. The other reasons involve the WIC program, which is administered by the Department of Agriculture and is unrelated to the FDA. Rewarding one of the agencies that contributed to the current crisis with more funding as a response to that same crisis is how you guarantee more crises in the future.
Republicans have a superior alternative available. Senator Mike Lee (R., Utah) has proposed the FORMULA Act, which (cheesy name aside) is a much better approach to the problem. It would waive baby-formula tariffs from friendly countries with high health standards (e.g., Australia, Japan, the U.K., and the European Union). It would also waive FDA regulations on labeling and facility approval that have made it nearly impossible to import safe baby formula from those friendly countries. It would make the newly available imported baby formula eligible for WIC beneficiaries to purchase.
——————
Yes to more capitalism. Yes to fewer dumb regulations. No to protectionism. And abolish the FDA.
The House of Representatives passed a bill yesterday that purports to address the baby-formula shortage. Introduced by House Democrats, the “Infant Formula Supplemental Appropriations Act” simply gives the Food and Drug Administration $28 million and doesn’t address any actual problems with the baby-formula market or the current shortage.
The bill passed 231 to 192, and all 192 votes against it came from Republicans. In response to criticism for voting against the bill, Representative Peter Meijer (R., Mich.) tweeted, “This one-page bill is just a $28M increase for FDA salaries. That’s it. If baby formula shortage was caused by an underfunded FDA, this would help. But it wasn’t.”
The FDA doesn’t need more money. As Meijer went on to say, the bill rewards “an agency that is performing its mission poorly with more money without connecting the funds requested to better achieving the mission. The moral hazard is self-evident.”
The FDA’s overly stringent regulation of baby formula — which mirrors its overly cautious approach to everything it regulates and costs American lives by denying safe treatments to patients who need them — is part of the reason the baby-formula market is so brittle in the first place. The other reasons involve the WIC program, which is administered by the Department of Agriculture and is unrelated to the FDA. Rewarding one of the agencies that contributed to the current crisis with more funding as a response to that same crisis is how you guarantee more crises in the future.
Republicans have a superior alternative available. Senator Mike Lee (R., Utah) has proposed the FORMULA Act, which (cheesy name aside) is a much better approach to the problem. It would waive baby-formula tariffs from friendly countries with high health standards (e.g., Australia, Japan, the U.K., and the European Union). It would also waive FDA regulations on labeling and facility approval that have made it nearly impossible to import safe baby formula from those friendly countries. It would make the newly available imported baby formula eligible for WIC beneficiaries to purchase.
——————
Yes to more capitalism. Yes to fewer dumb regulations. No to protectionism. And abolish the FDA.
acesfull86
Well-known member
https://reason.com/2022/05/27/the-fda-completely-botched-its-response-to-the-baby-formula-shortage/
In testimony to a House subcommittee this week, FDA Commissioner Robert Califf confirmed that a whistleblower report detailing potentially unsanitary conditions at the Abbott Nutrition baby formula plant in Michigan did not reach the proper officials at the agency because of a mistake in the agency's mailroom. The Washington Post reported earlier this week that the 34-page report took four months to reach the proper desk at the FDA. By the time it did, several infants had been sickened by tainted formula from the plant, which was shut down in February. That closure (along with protectionist regulations and trade policy) triggered the ongoing national shortage.
—————
Lol
In testimony to a House subcommittee this week, FDA Commissioner Robert Califf confirmed that a whistleblower report detailing potentially unsanitary conditions at the Abbott Nutrition baby formula plant in Michigan did not reach the proper officials at the agency because of a mistake in the agency's mailroom. The Washington Post reported earlier this week that the 34-page report took four months to reach the proper desk at the FDA. By the time it did, several infants had been sickened by tainted formula from the plant, which was shut down in February. That closure (along with protectionist regulations and trade policy) triggered the ongoing national shortage.
—————
Lol